Completed PHASE4 INTERVENTIONAL 2-arm NCT00964808

Norspan Versus Oxycontin as Postoperative Painkiller to Proximal Extracapsular Fractures of the Femur

Sponsor: Norpharma A/S

Updated 6 times since 2017 Last updated: Dec 5, 2014 Started: Sep 30, 2009 Primary completion: May 31, 2013 Completion: Aug 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00964808, this PHASE4 trial focuses on Pain, Postoperative and remains completed. Sponsored by Norpharma A/S, it has been updated 6 times since 2009, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Feb 2017 — Jun 2018 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE4

First recorded

Sep 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Norpharma A/S
Vejle Hospital

Data source: Vejle Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Vejle, Denmark